UCLA, UT Southwestern join NCCN

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

UCLA Jonsson Comprehensive Cancer Center and UT Southwestern Simmons Comprehensive Cancer Center are the newest members of the National Comprehensive Cancer Network.

Experts from both centers will now contribute to NCCN Clinical Practice Guidelines in Oncology.

“We look forward to joining our peer institutions and bringing our focus on cutting-edge research and top-quality cancer care to this association of the nation’s top cancer centers,” Michael Teitell, director of UCLA Jonsson Comprehensive Cancer Center, said in as statement.

“We are excited to be able to join forces with the other leading cancer centers who are part of NCCN,” John Sweetenham, associate director of Clinical Affairs, UT Southwestern Simmons Comprehensive Cancer Center, said in a statement. “Working with the other member institutions, we will ensure that the best possible evidence-based cancer care is available to patients throughout the nation and beyond. Our membership will bring the combined expertise of 30 elite cancer centers to the people of North Texas.”

In 2019, more than 1,500 experts from NCCN member institutions helped create and update NCCN Guidelines. Those guidelines provide the latest evidence- and expert consensus-based recommendations applying to 97% of cancers affecting patients in the United States, and also include prevention, screening, and supportive care topics.

Table of Contents

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login